MedTrace Logo

Water-only Fasting in the Treatment of Hypertension Patients

NCT04515095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-11-22

No results posted yet for this study

Summary

This purpose of this study is to examine the safety and feasibility of water-only fasting to treat hypertensive patients.

Conditions

Interventions

OTHER

Water-only Fasting

Participants consume only water for at least 7 days in an in-patient, residential setting with 24 hour medical supervision.

Sponsors & Collaborators

  • TrueNorth Health Foundation

    lead OTHER

Principal Investigators

  • Toshia R Myers, PhD · Director

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-16
Primary Completion
2021-09-29
Completion
2022-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515095 on ClinicalTrials.gov